418 related articles for article (PubMed ID: 36289064)
41. Navigating changes in
Durham SH; Le P; Cassano AT
J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
[No Abstract] [Full Text] [Related]
42. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
Saha S; Mara K; Pardi DS; Khanna S
Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
[TBL] [Abstract][Full Text] [Related]
43. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
44. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
[TBL] [Abstract][Full Text] [Related]
45. Cognitive function improvement after fecal microbiota transplantation in Alzheimer's dementia patient: a case report.
Park SH; Lee JH; Shin J; Kim JS; Cha B; Lee S; Kwon KS; Shin YW; Choi SH
Curr Med Res Opin; 2021 Oct; 37(10):1739-1744. PubMed ID: 34289768
[TBL] [Abstract][Full Text] [Related]
46. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
[TBL] [Abstract][Full Text] [Related]
47. Fecal microbiota transplantation stimulates type 2 and tolerogenic immune responses in a mouse model.
Moreau GB; Naz F; Petri WA
Anaerobe; 2024 Apr; 86():102841. PubMed ID: 38521227
[TBL] [Abstract][Full Text] [Related]
48. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
Mehta SR; Yen EF
Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
[TBL] [Abstract][Full Text] [Related]
49. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
50. Evolution of intestinal microbiome in a process of faecal microbiota transfer (FMT) in a patient with Clostridioides difficile infection: NGS analysis with different software programs.
Ventero MP; Espinosa N; Jover R; Guillen Y; Merino E; Rodríguez JC
Enferm Infecc Microbiol Clin (Engl Ed); 2021 Apr; 39(4):184-187. PubMed ID: 32680797
[TBL] [Abstract][Full Text] [Related]
51. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
Patwa SA; Ward C; Kelly CR
R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
[TBL] [Abstract][Full Text] [Related]
52. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
53. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
[TBL] [Abstract][Full Text] [Related]
54. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection.
Nooij S; Vendrik KEW; Zwittink RD; Ducarmon QR; Keller JJ; Kuijper EJ; Terveer EM;
Genome Med; 2024 Feb; 16(1):37. PubMed ID: 38419010
[TBL] [Abstract][Full Text] [Related]
55. Bacterial microbiome changes after fecal transplantation for recurrent Clostridioides difficile infection in the Brazilian center.
Terra DAA; de Oliveira Carvalho RD; da Silva TF; Dos Santos Freitas A; Góes-Neto A; Amarante VS; Azevedo V; Vilela EG; Coelho LGV; Silva ROS
Braz J Microbiol; 2024 Mar; 55(1):719-725. PubMed ID: 38158466
[TBL] [Abstract][Full Text] [Related]
56. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
[TBL] [Abstract][Full Text] [Related]
57. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
[TBL] [Abstract][Full Text] [Related]
58. Recovery of the gut microbiome following fecal microbiota transplantation.
Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
[TBL] [Abstract][Full Text] [Related]
59. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A
BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084
[TBL] [Abstract][Full Text] [Related]
60. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
